An observational study in Hip Pain &Disorders, sponsored by Sohag University. Active, not recruiting at 1 site in Egypt. Per ClinicalTrials.gov, last updated 2026-09-03.
Sponsored by Sohag University · Observational
To evaluate the role of Magnetic Resonance Imaging in the assessment and diagnosis of patients presenting with hip pain.
The hip joint is a deep ball-and-socket synovial joint formed by the articulation between the femoral head and the acetabulum, supported by the labrum, ligaments, and surrounding musculature. This structural complexity makes clinical evaluation alone insufficient for identifying the underlying pathology. Magnetic Resonance Imaging (MRI) has emerged as a key imaging modality for comprehensive assessment of both normal anatomy and pathological conditions affecting the hip joint
Sohag University is the lead sponsor of 1,230 studies on the registry; 636 are open to participants now.
Counted across the registry records on this site, refreshed daily.
the study population will consist of patients presenting with hip pain who are referred for MRI evaluation of the hip. patients of all age groups and both sexes will be eligible for inclusion. the study will assess MRI findings and characterize the underlying abnormalities associated with hip pain, including osseous, articular, and periarticular soft tissue abnormalities. patients with MRI contraindications or technically inadequate examination will be excluded.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
Contraindication
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
no intervention, participants will undergo MRI examination for assessment of hip pain and identification of underlying hip abnormalities
Diagnostic yield of MRI in identifying the underlying cause of hip pain.
Proportion of patients in whom MRI identifies a specific structural or pathological abnormality that may explain the presenting hip pain, including labral tears, cartilage abnormalities, femoroacetabular impingement, avascular necrosis, stress/insufficiency fractures, bone marrow edema, osteoarthritis, joint effusion/synovitis, tendinopathy, bursitis, and other periarticular soft-tissue abnormalities.
Time frame: At the time of MRI examination
Distribution of MRI-detected pathologies in patients presenting with hip pain.
Frequency and type of abnormalities detected by MRI, categorized into osseous, articular, labral, synovial, muscular, tendinous, bursal, and other soft-tissue abnormalities.
Time frame: at the time of MRI examination
Correlation between MRI findings and clinical presentation.
Assessment of the association between MRI abnormalities and clinical characteristics, including age, sex, laterality, duration and characteristics of hip pain, and relevant clinical diagnosis.
Time frame: At the time of MRI examination.
Plan to share: No — There are no plans to share individual participant data (IPD) due to privacy and confidentiality considerations.
No publications or documents are linked to this record.
Started Dec 2025 (actual). Primary completion is estimated for Jan 2027, 12 months after the start.
How these figures are worked out, and which studies are left out of them.
This study is active, not recruiting, as verified in Aug 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.